50 ACTIVITY OF TELAPREVIR ALONE OR IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 2 AND 3 HEPATITIS-C PATIENTS: INTERIM RESULTS OF STUDY C209
Graham R. FosterChristophe HézodeOspedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milano, Italy;J.‐P. BronowickiG. CarosiCharité -Campus Virchow Klinikum, Berlin, Germany;Ola WeilandOspedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milano, Italy;Lieselotte VerlindenInstitute of Nuclear Medicine,Rolf van HeeswijkHeritage Medical Research Clinic -University of Calgary, Calgary, Alberta,Tony VangeneugdenCharité -Campus Virchow Klinikum, Berlin, Germany;Gastón PicchioCharité -Campus Virchow Klinikum, Berlin, Germany;Maria Beumont‐MauvielHospital Universitario Gaffree & Guinle, Rio de Janeiro, Brazil;
ABI
Аннотация
Аннотация отсутствует.
Темы
Идентификаторы
Цитирования и источники
Цитирований: 0Использованных источников: 0
Показатели — AkademScholar · Скоро